estrogen receptor 中文意思是什麼

estrogen receptor 解釋
雌激素受體蛋白
  • estrogen : n. 【生物化學】雌（性）激素。
  • receptor : n. 【生物學】感受器；受體；【化學】接受器；受納體；【電學】感受器；接收器。
  1. Expression and localization of estrogen receptor

    變異型在胎盤組織的表達及定位
  2. Expression of estrogen receptor and in endometrial carcinoma

    在子宮內膜癌中表達的研究
  3. Expression of estrogen receptor mrna in epithelial ovar ian carcinoma

    在卵巢上皮性癌中的表達
  4. Osteoarthritis and gene polymorphism of estrogen receptor

    骨性關節炎與雌激素受體的基因多態性
  5. Association between estrogen receptor - gene polymorphism and vitiligo

    基因多態性與白癜風相關性研究
  6. The study found the increased risk most acute for cancer involving so - called estrogen - receptor positive tumors

    研究發現，西式飲食對雌激素受體陽性腫瘤作用最明顯。
  7. It could become the basis for deciding how patients with estrogen - receptor - positie breast cancer are treated clinically

    以前的研究表明，雌激素促進大多數乳癌的生長。
  8. It could become the basis for deciding how patients with estrogen - receptor - positive breast cancer are treated clinically

    它可決定雌激素受體陽性的乳癌患者如何臨床治療。
  9. Study limitations included the lack of recording for tumor grade and estrogen - receptor status, and the possibility of misclassification of some hereditary cases

    本研究的局限性包括缺乏腫瘤分級和雌激素受體狀態的記錄，以及可能對某些遺傳性病例分類錯誤。
  10. Conclusions the recurrence score has been vakidated as quantifying the kikekihood of distant recurrence in tamoxifen - treated patients with node - negative ? estrogen - receptor - positive breast cancer

    結論研究證實復發評分可量化淋巴結陰性、雌激素受體陽性、接受他莫昔芬治療的乳腺癌患者的遠處復發可能性。
  11. According to the national cancer institute, about two - thirds of women with breast cancer have estrogen - receptor - positive breast cancer, in which tumor growth is regulated by the natural female hormone estrogen

    根據國家癌癥研究所的資料，大約2 / 3的女性乳癌患者雌激素受體陽性，腫瘤的生長受天然的雌激素調控。
  12. Since evidence shows anti - estrogen drugs will fail in a many patients with estrogen - receptor - positive breast cancer, says knudsen, our research suggests that physicians should examine both estrogen receptor status and rb tumor suppressor status during the initial diagnosis, in order to prescribe the most effective therapy for that specific patient ' s cancer.

    證據表明，抗雌激素藥物對雌激素受體陽性乳癌將失效，我們的研究提示，為了給那些特殊癌癥患者制定最有效的治療方法，醫生應該在開始診斷時檢測雌激素受體和rb抑癌基因狀況。
  13. Since eidence shows anti - estrogen drugs will fail in a many patients with estrogen - receptor - positie breast cancer, says knudsen, our research suggests that physicians should examine both estrogen receptor status and rb tumor suppressor status during the initial diagnosis, in order to prescribe the most effectie therapy for that specific patient ' s cancer.

    證據表明，抗雌激素* *物對雌激素受體陽性乳癌將失效，我們的研究提示，為了給那些特殊癌癥患者制定最有效的治療方法，醫生應該在開始診斷時檢測雌激素受體和rb抑癌基因狀況。
  14. Study on the expression levels of estrogen receptor of fat cell in different parts of body

    脂肪細胞雌激素受體的測定及表達水平的研究
  15. Detection of estrogen receptor of endometrium precancerosis blocked by pregnancy hormone

    孕激素阻斷子宮內膜癌前病變癌變雌孕激素受體的測定
  16. Abstract : estrogen receptor ( er ) and androgen receptor ( ar ) assays were performed with fluorescent histochemical method in 89 cases of bladder carcinoma. 77 cases were followed up for at leazt six years. the tumor recurrence occurred in 32 ( 41. 56 % )

    文摘:採用熒光組織化學法測定了89例膀胱移行細胞癌雌雄激素受體的表達，獲長期隨訪的77例中有32例復發，復發率為41 . 56 % 。
  17. In recent years, advanced research on selective estrogen receptor modulators has been made, making the treatment of menopausal syndrome safer and more effective

    近年來，選擇性雌激素受體調節劑的研究取得一定進展，將使更年期綜合征的治療更趨安全有效。
  18. Estrogen receptor ( er ), an important transcription factor belonging to the nuclear receptor superfamily, plays a key role in reproductive, cardiovascular and central nervous systems and bone tissue

    摘要雌激素受體屬于核受體超家族成員，是一類重要的核轉錄因子，它在生殖系統、骨組織、心血管和中樞神經系統中發揮著重要的生理作用，是治療骨質疏鬆和乳腺癌的重要藥物作用靶標。
  19. There are a and 3 subunits of estrogen receptor ( er ) subtypes. they are different in their distribution, density and mediated action. er can be expressed in nucleus or in cellular membrane

    雌激素受體（ er ）屬于類固醇受體超家族的核受體，具有a和日兩種亞型，此二者在各種組織分佈及密度各異。
  20. Here we show that 27 - hydroxycholesterol ( 27hc ), an abundant cholesterol metabolite that is elevated with hypercholesterolemia and found in atherosclerotic lesions, is a competitive antagonist of estrogen receptor action in the vasculature

    在此我們發現27 -羥基膽甾醇（ 27hc ）是一種含量豐富的膽固醇代謝產物，它的過量引起高膽固醇血癥並存於粥樣硬化病變中，在血管中是雌激素受體競爭性拮抗劑。
分享友人
分享到 Line

分享到臉書